BC
MNTA

Brinker Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Brinker Capital’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-19,110
Closed -$503K – 1014
2018
Q3 		$503K Buy
19,110
+1,554
+9% +$42K 0.02% 717
2018
Q2 		$359K Buy
17,556
+1,177
+7% +$25.3K 0.01% 814
2018
Q1 		$297K Buy
16,379
+977
+6% +$16.3K 0.01% 855
2017
Q4 		$215K Sell
15,402
-5,427
-26% -$73.4K 0.01% 939
2017
Q3 		$385K Sell
20,829
-214
-1% -$3.58K 0.02% 745
2017
Q2 		$356K Sell
21,043
-371
-2% -$5.65K 0.02% 584
2017
Q1 		$286K Buy
21,414
+615
+3% +$9.63K 0.01% 797
2016
Q4 		$313K Buy
+20,799
New +$275K 0.02% 567

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return